rs10200271
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_001017915.3(INPP5D):c.665+1699A>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0389 in 152,126 control chromosomes in the GnomAD database, including 139 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.039 ( 139 hom., cov: 32)
Consequence
INPP5D
NM_001017915.3 intron
NM_001017915.3 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -2.01
Publications
5 publications found
Genes affected
INPP5D (HGNC:6079): (inositol polyphosphate-5-phosphatase D) This gene is a member of the inositol polyphosphate-5-phosphatase (INPP5) family and encodes a protein with an N-terminal SH2 domain, an inositol phosphatase domain, and two C-terminal protein interaction domains. Expression of this protein is restricted to hematopoietic cells where its movement from the cytosol to the plasma membrane is mediated by tyrosine phosphorylation. At the plasma membrane, the protein hydrolyzes the 5' phosphate from phosphatidylinositol (3,4,5)-trisphosphate and inositol-1,3,4,5-tetrakisphosphate, thereby affecting multiple signaling pathways. The protein is also partly localized to the nucleus, where it may be involved in nuclear inositol phosphate signaling processes. Overall, the protein functions as a negative regulator of myeloid cell proliferation and survival. Mutations in this gene are associated with defects and cancers of the immune system. Deficiencies in the encoded protein, SHIP1, have been associated with Inflammatory Bowel Disease types such as Crohn's Disease and Ulcerative Colitis. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, Jul 2020]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-1.04).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.053 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| INPP5D | NM_001017915.3 | c.665+1699A>C | intron_variant | Intron 5 of 26 | ENST00000445964.6 | NP_001017915.1 | ||
| INPP5D | NM_005541.5 | c.662+1699A>C | intron_variant | Intron 5 of 26 | NP_005532.2 | |||
| INPP5D | XM_047444219.1 | c.665+1699A>C | intron_variant | Intron 5 of 25 | XP_047300175.1 | |||
| INPP5D | XM_047444220.1 | c.662+1699A>C | intron_variant | Intron 5 of 25 | XP_047300176.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| INPP5D | ENST00000445964.6 | c.665+1699A>C | intron_variant | Intron 5 of 26 | 1 | NM_001017915.3 | ENSP00000405338.2 | |||
| INPP5D | ENST00000359570.9 | c.662+1699A>C | intron_variant | Intron 5 of 26 | 1 | ENSP00000352575.7 | ||||
| INPP5D | ENST00000451407.4 | n.778+1699A>C | intron_variant | Intron 5 of 5 | 2 |
Frequencies
GnomAD3 genomes AF: 0.0389 AC: 5913AN: 152008Hom.: 138 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
5913
AN:
152008
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.0389 AC: 5919AN: 152126Hom.: 139 Cov.: 32 AF XY: 0.0372 AC XY: 2767AN XY: 74404 show subpopulations
GnomAD4 genome
AF:
AC:
5919
AN:
152126
Hom.:
Cov.:
32
AF XY:
AC XY:
2767
AN XY:
74404
show subpopulations
African (AFR)
AF:
AC:
2278
AN:
41494
American (AMR)
AF:
AC:
535
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
AC:
95
AN:
3466
East Asian (EAS)
AF:
AC:
0
AN:
5182
South Asian (SAS)
AF:
AC:
64
AN:
4812
European-Finnish (FIN)
AF:
AC:
153
AN:
10606
Middle Eastern (MID)
AF:
AC:
12
AN:
294
European-Non Finnish (NFE)
AF:
AC:
2693
AN:
67972
Other (OTH)
AF:
AC:
87
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.510
Heterozygous variant carriers
0
292
585
877
1170
1462
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
66
132
198
264
330
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
38
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.